Michael D. LaFleur

1.6k total citations · 1 hit paper
12 papers, 1.2k citations indexed

About

Michael D. LaFleur is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Michael D. LaFleur has authored 12 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 5 papers in Molecular Biology and 5 papers in Epidemiology. Recurrent topics in Michael D. LaFleur's work include Antifungal resistance and susceptibility (5 papers), Fungal Infections and Studies (4 papers) and Bacterial biofilms and quorum sensing (3 papers). Michael D. LaFleur is often cited by papers focused on Antifungal resistance and susceptibility (5 papers), Fungal Infections and Studies (4 papers) and Bacterial biofilms and quorum sensing (3 papers). Michael D. LaFleur collaborates with scholars based in United States, China and Canada. Michael D. LaFleur's co-authors include Kim Lewis, Carol A. Kumamoto, Qing‐guo Qi, Brian P. Conlon, K. Coleman, Steve N. Leonard, Ernesto Nakayasu, Richard Smith, Vincent M. Isabella and Joshua Adkins and has published in prestigious journals such as Nature, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Michael D. LaFleur

12 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Activated ClpP kills persisters and eradicates a chronic biofilm infection

2013 520 citations Brian P. Conlon, Ernesto Nakayasu et al. Nature profile →

Peers

Michael D. LaFleur

MB

ID

MM

GENET

EPIDE

Guangchun Bai United States

Reiko Kariyama Japan

Asher Brauner Israel

Meera Unnikrishnan United Kingdom

Pavel Branny Czechia

Tania Wong Fok Lung United States

Clarissa Pozzi United States

Niles P. Donegan United States

Sarah Dubrac France

R E Kessler United States

Guangchun Bai United States

Michael D. LaFleur

647 ×1.0

MB

509 ×0.9

ID

122 ×0.4

MM

286 ×1.1

GENET

420 ×1.8

EPIDE

Citations per year, relative to Michael D. LaFleur Michael D. LaFleur (= 1×) peers Guangchun Bai

Countries citing papers authored by Michael D. LaFleur

Since Specialization

Citations

This map shows the geographic impact of Michael D. LaFleur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael D. LaFleur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael D. LaFleur more than expected).

Fields of papers citing papers by Michael D. LaFleur

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael D. LaFleur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael D. LaFleur. The network helps show where Michael D. LaFleur may publish in the future.

Co-authorship network of co-authors of Michael D. LaFleur

This figure shows the co-authorship network connecting the top 25 collaborators of Michael D. LaFleur. A scholar is included among the top collaborators of Michael D. LaFleur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael D. LaFleur. Michael D. LaFleur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

LaFleur, Michael D., et al.. (2022). Targeting Helicobacter pylori for antibacterial drug discovery with novel therapeutics. Current Opinion in Microbiology. 70. 102203–102203. 11 indexed citations

2.

Gandt, Autumn Brown, Kevin Moran, Lalit Kumar Sharma, et al.. (2021). The Discovery and Development of Thienopyrimidines as Inhibitors of Helicobacter pylori That Act through Inhibition of the Respiratory Complex I. ACS Infectious Diseases. 7(5). 1044–1058. 8 indexed citations

3.

Griffith, Elizabeth C., Ying Zhao, Aman Preet Singh, et al.. (2019). Ureadepsipeptides as ClpP Activators. ACS Infectious Diseases. 5(11). 1915–1925. 33 indexed citations

4.

Arya, Anu, et al.. (2019). Pharmacodynamics of ClpP-Activating Antibiotic Combinations against Gram-Positive Pathogens. Antimicrobial Agents and Chemotherapy. 64(1). 6 indexed citations

5.

Gandt, Autumn Brown, Elizabeth C. Griffith, Rajendra Tangallapally, et al.. (2018). In Vivo and In Vitro Effects of a ClpP-Activating Antibiotic against Vancomycin-Resistant Enterococci. Antimicrobial Agents and Chemotherapy. 62(8). 26 indexed citations

6.

Gavrish, Ekaterina, Chao Chen, E. Jeffrey North, et al.. (2014). In Vitro and In Vivo Activities of HPi1, a Selective Antimicrobial against Helicobacter pylori. Antimicrobial Agents and Chemotherapy. 58(6). 3255–3260. 8 indexed citations

7.

Conlon, Brian P., Ernesto Nakayasu, L Fleck, et al.. (2013). Activated ClpP kills persisters and eradicates a chronic biofilm infection. Nature. 503(7476). 365–370. 520 indexed citations breakdown →

8.

LaFleur, Michael D., Lingmei Sun, John H. Keating, et al.. (2013). Potentiation of Azole Antifungals by 2-Adamantanamine. Antimicrobial Agents and Chemotherapy. 57(8). 3585–3592. 30 indexed citations

9.

LaFleur, Michael D., Edinson Lucumi, Andrew D. Napper, Scott L. Diamond, & Kim Lewis. (2011). Novel high-throughput screen against Candida albicans identifies antifungal potentiators and agents effective against biofilms. Journal of Antimicrobial Chemotherapy. 66(4). 820–826. 48 indexed citations

10.

LaFleur, Michael D.. (2011). Candida albicans Biofilms, Heterogeneity and Antifungal Drug Tolerance. 5(1). 21–28. 5 indexed citations

11.

LaFleur, Michael D., Qing‐guo Qi, & Kim Lewis. (2009). Patients with Long-Term Oral Carriage Harbor High-Persister Mutants of Candida albicans. Antimicrobial Agents and Chemotherapy. 54(1). 39–44. 181 indexed citations

12.

LaFleur, Michael D., Carol A. Kumamoto, & Kim Lewis. (2006). Candida albicans Biofilms Produce Antifungal-Tolerant Persister Cells. Antimicrobial Agents and Chemotherapy. 50(11). 3839–3846. 369 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact